⌘K

Login Start Free

Home/Filings/4/0001209191-20-035923

4//SEC Filing

Aldag Jorn 4

Accession 0001209191-20-035923

CIK 0001622229other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:22 PM ET

Size

5.4 KB

Accession

0001209191-20-035923

Insider Transaction Report

Form 4

Period: 2020-06-09

Unum Therapeutics Inc.UMRX

Director

Transactions

Award
Stock Option (Right to Buy)
2020-06-09+14,331→ 14,331 total
Exercise: $0.63Exp: 2030-06-09→ Common Stock (14,331 underlying)

Footnotes (1)

[F1]This option shall vest in full on the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Unum Therapeutics Inc.

CIK 0001622229

Entity typeother

Related Parties

1

filerCIK 0001734412

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 4:22 PM ET
Size: 5.4 KB

View on SEC.gov